JP6641271B2 - 睡眠を調整する器械及び方法 - Google Patents
睡眠を調整する器械及び方法 Download PDFInfo
- Publication number
- JP6641271B2 JP6641271B2 JP2016530061A JP2016530061A JP6641271B2 JP 6641271 B2 JP6641271 B2 JP 6641271B2 JP 2016530061 A JP2016530061 A JP 2016530061A JP 2016530061 A JP2016530061 A JP 2016530061A JP 6641271 B2 JP6641271 B2 JP 6641271B2
- Authority
- JP
- Japan
- Prior art keywords
- sleep
- temperature
- heat transfer
- applicator
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000007958 sleep Effects 0.000 title claims description 334
- 238000000034 method Methods 0.000 title description 96
- 238000012546 transfer Methods 0.000 claims description 131
- 210000001061 forehead Anatomy 0.000 claims description 119
- 230000001965 increasing effect Effects 0.000 claims description 55
- 230000003860 sleep quality Effects 0.000 claims description 44
- 238000010438 heat treatment Methods 0.000 claims description 22
- 230000004622 sleep time Effects 0.000 claims description 19
- 239000012530 fluid Substances 0.000 claims description 18
- 238000004904 shortening Methods 0.000 claims description 7
- 238000004891 communication Methods 0.000 claims description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 127
- 206010022437 insomnia Diseases 0.000 description 124
- 230000000694 effects Effects 0.000 description 55
- 230000037053 non-rapid eye movement Effects 0.000 description 33
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 33
- 238000001816 cooling Methods 0.000 description 30
- 230000037322 slow-wave sleep Effects 0.000 description 28
- 238000010792 warming Methods 0.000 description 27
- 238000011282 treatment Methods 0.000 description 24
- 210000003128 head Anatomy 0.000 description 23
- 230000036757 core body temperature Effects 0.000 description 21
- 230000008859 change Effects 0.000 description 20
- 210000002569 neuron Anatomy 0.000 description 20
- 210000004556 brain Anatomy 0.000 description 19
- 239000000463 material Substances 0.000 description 19
- 230000007423 decrease Effects 0.000 description 18
- 230000004060 metabolic process Effects 0.000 description 16
- 230000037007 arousal Effects 0.000 description 15
- 230000033228 biological regulation Effects 0.000 description 15
- 210000003016 hypothalamus Anatomy 0.000 description 15
- 238000012216 screening Methods 0.000 description 15
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 14
- 238000011160 research Methods 0.000 description 13
- 230000004620 sleep latency Effects 0.000 description 13
- 230000008667 sleep stage Effects 0.000 description 13
- 241000700159 Rattus Species 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 210000003051 thermoreceptor Anatomy 0.000 description 12
- 108091008689 thermoreceptors Proteins 0.000 description 12
- 239000003570 air Substances 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 230000001976 improved effect Effects 0.000 description 11
- 230000002093 peripheral effect Effects 0.000 description 11
- 230000004044 response Effects 0.000 description 11
- 208000019116 sleep disease Diseases 0.000 description 11
- 230000001331 thermoregulatory effect Effects 0.000 description 11
- 230000002490 cerebral effect Effects 0.000 description 10
- 230000009850 completed effect Effects 0.000 description 10
- 210000005153 frontal cortex Anatomy 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 230000028016 temperature homeostasis Effects 0.000 description 10
- 238000013461 design Methods 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 208000019901 Anxiety disease Diseases 0.000 description 8
- 206010062519 Poor quality sleep Diseases 0.000 description 8
- 230000004153 glucose metabolism Effects 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 230000036506 anxiety Effects 0.000 description 7
- 230000036760 body temperature Effects 0.000 description 7
- 229960002504 capsaicin Drugs 0.000 description 7
- 235000017663 capsaicin Nutrition 0.000 description 7
- 208000035475 disorder Diseases 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- 210000002442 prefrontal cortex Anatomy 0.000 description 7
- 241000282412 Homo Species 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 208000010340 Sleep Deprivation Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 208000020016 psychiatric disease Diseases 0.000 description 6
- 230000004461 rapid eye movement Effects 0.000 description 6
- 230000002123 temporal effect Effects 0.000 description 6
- 230000002747 voluntary effect Effects 0.000 description 6
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 5
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000007717 exclusion Effects 0.000 description 5
- 210000002683 foot Anatomy 0.000 description 5
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 102100029547 Ras-related protein Rab-39B Human genes 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000036626 alertness Effects 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000001149 cognitive effect Effects 0.000 description 4
- 238000002591 computed tomography Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000000517 effect on sleep Effects 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 239000013529 heat transfer fluid Substances 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 238000002483 medication Methods 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000001936 parietal effect Effects 0.000 description 4
- 210000003814 preoptic area Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000001103 thalamus Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- CEGXZKXILQSJHO-AKNDJLBFSA-N (3R,4S,5R)-3,4,5,6-tetrahydroxyhexan(18F)oyl fluoride Chemical compound [18F]C(=O)C[C@@H](O)[C@H](O)[C@H](O)CO CEGXZKXILQSJHO-AKNDJLBFSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 241000283984 Rodentia Species 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000007877 drug screening Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000013632 homeostatic process Effects 0.000 description 3
- 230000000147 hypnotic effect Effects 0.000 description 3
- 230000002267 hypothalamic effect Effects 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 230000037323 metabolic rate Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 210000004279 orbit Anatomy 0.000 description 3
- 230000007310 pathophysiology Effects 0.000 description 3
- 230000008447 perception Effects 0.000 description 3
- 230000002085 persistent effect Effects 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 208000011117 substance-related disease Diseases 0.000 description 3
- 210000003371 toe Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 2
- 208000020925 Bipolar disease Diseases 0.000 description 2
- 241001669679 Eleotris Species 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 206010021079 Hypopnoea Diseases 0.000 description 2
- 206010027590 Middle insomnia Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 101710122057 Phospholemman-like protein Proteins 0.000 description 2
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 2
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 239000012080 ambient air Substances 0.000 description 2
- 208000008784 apnea Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 239000002876 beta blocker Substances 0.000 description 2
- 229940097320 beta blocking agent Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000133 brain stem Anatomy 0.000 description 2
- 238000004422 calculation algorithm Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 210000003710 cerebral cortex Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000027288 circadian rhythm Effects 0.000 description 2
- 230000019771 cognition Effects 0.000 description 2
- 229940124301 concurrent medication Drugs 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000002996 emotional effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 210000004326 gyrus cinguli Anatomy 0.000 description 2
- 210000001320 hippocampus Anatomy 0.000 description 2
- 230000003284 homeostatic effect Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000001259 mesencephalon Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000004799 sedative–hypnotic effect Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 230000004617 sleep duration Effects 0.000 description 2
- 208000020685 sleep-wake disease Diseases 0.000 description 2
- 230000037046 slow wave activity Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 238000007910 systemic administration Methods 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 208000011688 Generalised anxiety disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020100 Hip fracture Diseases 0.000 description 1
- 206010048533 Hypervigilance Diseases 0.000 description 1
- 206010021034 Hypometabolism Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241000699673 Mesocricetus auratus Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 208000008705 Nocturnal Myoclonus Syndrome Diseases 0.000 description 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000097929 Porphyria Species 0.000 description 1
- 208000010642 Porphyrias Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000003782 Raynaud disease Diseases 0.000 description 1
- 208000012322 Raynaud phenomenon Diseases 0.000 description 1
- 102100038338 Rho-related GTP-binding protein RhoH Human genes 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 208000024799 Thyroid disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 229940094070 ambien Drugs 0.000 description 1
- 210000004727 amygdala Anatomy 0.000 description 1
- 238000004164 analytical calibration Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000000164 antipsychotic agent Substances 0.000 description 1
- 229940005529 antipsychotics Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000000949 anxiolytic effect Effects 0.000 description 1
- 229940005530 anxiolytics Drugs 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000028683 bipolar I disease Diseases 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 230000037086 body physiology Effects 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000008309 brain mechanism Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 210000002932 cholinergic neuron Anatomy 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 238000009225 cognitive behavioral therapy Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000007585 cortical function Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000959 cryoprotective effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 229940124581 decongestants Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000002451 diencephalon Anatomy 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 208000024732 dysthymic disease Diseases 0.000 description 1
- 210000002049 efferent pathway Anatomy 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000010291 electrical method Methods 0.000 description 1
- 210000003372 endocrine gland Anatomy 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 1
- 208000029364 generalized anxiety disease Diseases 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 206010020765 hypersomnia Diseases 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000012482 interaction analysis Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000010295 mobile communication Methods 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007230 neural mechanism Effects 0.000 description 1
- 238000002610 neuroimaging Methods 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000000446 orexinergic effect Effects 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 208000019906 panic disease Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 208000023515 periodic limb movement disease Diseases 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 208000022821 personality disease Diseases 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012782 phase change material Substances 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000009914 physiological arousal Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 208000028173 post-traumatic stress disease Diseases 0.000 description 1
- 210000002970 posterior hypothalamus Anatomy 0.000 description 1
- 230000002360 prefrontal effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000009597 pregnancy test Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000006903 response to temperature Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000002859 sleep apnea Diseases 0.000 description 1
- 230000008665 sleep physiology Effects 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 201000009032 substance abuse Diseases 0.000 description 1
- 231100000736 substance abuse Toxicity 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002791 sympathovagal effect Effects 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 230000003461 thalamocortical effect Effects 0.000 description 1
- 230000008542 thermal sensitivity Effects 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 208000021510 thyroid gland disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000009184 walking Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229960001475 zolpidem Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0066—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/364—General characteristics of the apparatus related to heating or cooling by chemical reaction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/3653—General characteristics of the apparatus related to heating or cooling by Joule effect, i.e. electric resistance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/366—General characteristics of the apparatus related to heating or cooling by liquid heat exchangers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/06—Head
- A61M2210/0606—Face
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/08—Other bio-electrical signals
- A61M2230/10—Electroencephalographic signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/50—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/63—Motion, e.g. physical activity
Description
本明細書において言及される全ての非特許文献(又は刊行物)及び特許文献は、個々の非特許文献又は特許文献の各々の内容が参照による引用プラクティスによって具体的に且つ個々に記載されていたものとするのと同じ程度に、参照により引用されてこれらの記載内容全体が本明細書の一部となっているものとする。
本発明は、以下のような態様であっても良い。
[12]
患者の睡眠の質を向上させる方法であって、前記方法は、
熱伝達領域を有するアプリケータを前記熱伝達領域が前記被験者の額に接触するよう位置決めするステップを含み、前記熱伝達領域は、前記被験者の顔面の眼窩周囲領域には接触せず、
前記熱伝達領域の温度を周囲温度よりも温かい標的温度範囲内に維持して前記被験者の睡眠の質を高めるステップを含む、方法。
[13]
前記位置決めステップは、前記アプリケータを前記熱伝達領域が前記被験者の頬に接触しないよう位置決めするステップを含む、[12]記載の方法。
[14]
前記アプリケータの前記位置決め前に使い捨てインターフェースを前記アプリケータ上に配置するステップを更に含み、前記使い捨てインターフェースは、前記熱伝達領域の少なくとも一部を形成すると共に前記患者の額に接触するよう構成されている、[12]記載の方法。
[15]
前記アプリケータを位置決めするステップは、前記熱伝達領域を前記熱伝達領域が前記被験者の頭の頂部又は後部に接触しないよう位置決めするステップを含む、[12]記載の方法。
[16]
前記アプリケータを位置決めするステップは、前記熱伝達領域を前記被験者の額にのみ当てて位置決めするステップを含む、[12]記載の方法。
[17]
前記熱伝達領域の温度を維持するステップは、前記温度を約25℃〜約40℃の標的温度範囲内に維持するステップを含む、[12]記載の方法。
[18]
前記熱伝達領域の温度を維持するステップは、前記温度を周囲温度よりも少なくとも約0.5℃高いが約40℃以下である標的温度範囲内に維持するステップを含む、[12]記載の方法。
[19]
前記熱伝達領域の温度を維持するステップは、前記温度を少なくとも約1時間、標的温度範囲内に維持するステップを含む、[12]記載の方法。
[20]
前記熱伝達領域の温度を維持するステップは、前記温度を少なくとも約4時間、標的温度範囲内に維持するステップを含む、[12]記載の方法。
[21]
前記熱伝達領域の温度を維持するステップは、前記温度を前記被験者の睡眠期間全体にわたり標的温度範囲内に維持するステップを含む、[12]記載の方法。
[22]
患者の睡眠の質を向上させる方法であって、前記方法は、
使い捨てインターフェースをアプリケータ上に配置するステップを含み、前記使い捨てインターフェースは、前記アプリケータの熱伝達領域の少なくとも一部を形成すると共に前記患者の額に接触するよう構成され、
前記アプリケータの前記熱伝達領域を前記被験者の額に当てて配置するステップを含み、
前記熱伝達領域の温度を少なくとも1時間、周囲温度よりも少なくとも0.5℃だけ温かく且つ約40℃以下の標的温度範囲内に維持するステップを含む、方法。
[23]
前記アプリケータの熱伝達領域を配置するステップは、前記熱伝達領域を、当該熱伝達領域が前記被験者の額にのみ接触するよう配置するステップを含む、[22]記載の方法。
[24]
前記アプリケータの熱伝達領域を配置するステップは、前記熱伝達領域を、当該熱伝達領域が前記被験者の顔面の眼窩周囲領域又は頬領域に接触しないよう配置するステップを含む、[22]記載の方法。
[25]
入眠潜時を短縮する方法であって、前記方法は、
覚醒している被験者の額上にアプリケータを位置決めして前記アプリケータの熱伝達領域が前記被験者の額に接触するようにするステップを含み、前記熱伝達領域は、前記被験者の顔面の眼窩周囲領域又は頬領域には接触せず、
前記患者を睡眠させるよう準備するステップを含み、
前記熱伝達領域の温度を少なくとも15分間、周囲温度よりも温かい標的温度範囲内に維持することによって入眠潜時を短縮するステップを含む、方法。
[26]
前記アプリケータの前記位置決め前に使い捨てインターフェースを前記アプリケータ上に配置するステップを更に含み、前記使い捨てインターフェースは、前記熱伝達領域の少なくとも一部を形成すると共に前記患者の額に接触するよう構成されている、[25]記載の方法。
[27]
前記アプリケータを位置決めするステップは、前記熱伝達領域を、当該熱伝達領域が前記被験者の頭の頂部又は後部に接触しないよう位置決めするステップを含む、[25]記載の方法。
[28]
前記アプリケータを位置決めするステップは、前記熱伝達領域を前記被験者の額にのみ当てて位置決めするステップを含む、[25]記載の方法。
[29]
前記熱伝達領域の温度を維持するステップは、前記温度を約25℃〜約40℃の標的温度範囲内に維持するステップを含む、[25]記載の方法。
[30]
前記熱伝達領域の温度を維持するステップは、前記温度を周囲温度よりも少なくとも約0.5℃高いが約40℃以下である標的温度範囲内に維持するステップを含む、[25]記載の方法。
[31]
前記熱伝達領域の温度を維持するステップは、前記温度を少なくとも約1時間、標的温度範囲内に維持するステップを含む、[25]記載の方法。
[32]
前記熱伝達領域の温度を維持するステップは、前記温度を少なくとも約4時間、標的温度範囲内に維持するステップを含む、[25]記載の方法。
[33]
前記熱伝達領域の温度を維持するステップは、前記温度を前記被験者の睡眠期間全体にわたり標的温度範囲内に維持するステップを含む、[25]記載の方法。
[34]
入眠潜時を短縮する方法であって、前記方法は、
使い捨てインターフェースをアプリケータ上に配置するステップを含み、前記使い捨てインターフェースは、前記アプリケータの熱伝達領域の少なくとも一部を形成すると共に患者の額に接触するよう構成され、
前記アプリケータを覚醒している被験者の額上に位置決めして前記熱伝達領域が前記被験者の額に接触するようにするステップを含み、
前記熱伝達領域の温度を少なくとも15分間、周囲温度よりも温かい標的温度範囲内に維持することによって入眠潜時を短縮するステップを含む、方法。
[35]
睡眠時間を延長する方法であって、前記方法は、
アプリケータを被験者の額上に位置決めして前記アプリケータの熱伝達領域が前記被験者の額に接触するようにするステップを含み、前記熱伝達領域は、前記被験者の顔面の眼窩領域又は頬領域に接触せず、
前記被験者が睡眠している間、前記熱伝達領域の温度を少なくとも15分間、周囲温度よりも温かい標的温度範囲内に維持することによって睡眠時間を延長するステップを含む、方法。
[36]
前記アプリケータの前記位置決め前に使い捨てインターフェースを前記アプリケータ上に配置するステップを更に含み、前記使い捨てインターフェースは、前記熱伝達領域の少なくとも一部を形成すると共に前記患者の額に接触するよう構成されている、[35]記載の方法。
[37]
前記アプリケータを位置決めするステップは、前記熱伝達領域を前記熱伝達領域が前記被験者の頭の頂部又は後部に接触しないよう位置決めするステップを含む、[35]記載の方法。
[38]
前記アプリケータを位置決めするステップは、前記熱伝達領域を前記被験者の額にのみ当てて位置決めするステップを含む、[35]記載の方法。
[39]
前記熱伝達領域の温度を維持するステップは、前記温度を約25℃〜約40℃の標的温度範囲内に維持するステップを含む、[35]記載の方法。
[40]
前記熱伝達領域の温度を維持するステップは、前記温度を周囲温度よりも少なくとも約0.5℃高いが約40℃以下である標的温度範囲内に維持するステップを含む、[35]記載の方法。
[41]
前記熱伝達領域の温度を維持するステップは、前記温度を少なくとも約1時間、標的温度範囲内に維持するステップを含む、[25]記載の方法。
[42]
前記熱伝達領域の温度を維持するステップは、前記温度を前記被験者の睡眠期間全体にわたり標的温度範囲内に維持するステップを含む、[35]記載の方法。
Claims (8)
- 入眠潜時を短縮し、睡眠時間を延長すると共に/或いは1期睡眠に対する熟睡期の時間を延長することによって睡眠の質を高める器械であって、前記器械は、
被験者の額に装着されるよう構成されたアプリケータを有し、前記アプリケータは、前記被験者の額に接触するが、前記被験者の顔面の眼窩周囲領域には接触しないよう構成された熱伝達領域を有し、
ヒータ及び前記ヒータを制御するコントローラを含む温度調節器ユニットを有し、前記ヒータは、前記熱伝達領域と熱的連絡状態にあると共に、循環する流体を用いることなく前記熱伝達領域を直接加熱し、
前記温度調節器ユニットに作動的に接続されると共に、周囲温度を測定するよう構成された温度センサを更に有し、
更に、前記コントローラは、前記熱伝達領域が30分を超える時間の間、周囲温度よりも温かく且つ27℃と40℃の間の温度の状態にあるよう前記ヒータの温度を制御し、最高温度が40℃に制限されるよう構成されている、器械。 - 入眠潜時を短縮し、睡眠時間を延長すると共に/或いは1期睡眠に対する熟睡期の時間を延長することによって睡眠の質を高める器械であって、前記器械は、
被験者の額に装着されるよう構成されたアプリケータを有し、前記アプリケータは、前記被験者の額に接触するが、前記被験者の顔面の眼窩周囲領域又は頬領域には接触しないよう構成された熱伝達領域を有し、
ヒータと、クーラと、前記ヒータ及び前記クーラを制御するコントローラとを含む温度調節器ユニットを有し、前記ヒータ及び前記クーラは、前記熱伝達領域と熱的連絡状態にあると共に、循環する流体を用いることなく前記熱伝達領域を直接加熱し、
前記温度調節器ユニットに作動的に接続されると共に、周囲温度を測定するよう構成された温度センサを更に有し、
更に、前記コントローラは、前記熱伝達領域が30分を超える時間の間、27℃と40℃の間であり且つ周囲温度よりも温かい温度の状態にあるよう前記ヒータ及び前記クーラの温度を制御し、最高温度が40℃未満に制限されるよう構成されている、器械。 - 前記アプリケータは、前記熱伝達領域が前記額にのみ接触するよう構成されている、請求項1又は2記載の器械。
- 前記アプリケータは、前記熱伝達領域が前記被験者の顔面の頬領域に接触しないよう構成されている、請求項1記載の器械。
- 前記温度調節器ユニットの前記ヒータは、ジュール発熱体を含む、請求項1又は2記載の器械。
- 前記コントローラは、1時間を超える時間の間、前記標的温度を維持するよう構成されている、請求項1又は2記載の器械。
- 前記コントローラは、2時間を超える時間の間、前記標的温度を維持するよう構成されている、請求項1又は2記載の器械。
- 前記温度調節器ユニットは、クーラを更に含み、前記コントローラは、前記クーラを制御するよう構成され、前記クーラは、前記熱伝達領域と熱的連絡状態にあり、更に、前記コントローラは、前記熱伝達領域の温度を決定するよう前記ヒータ及び前記クーラの温度を制御するよう構成されている、請求項1記載の器械。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361859161P | 2013-07-26 | 2013-07-26 | |
US61/859,161 | 2013-07-26 | ||
PCT/US2014/048128 WO2015013576A1 (en) | 2013-07-26 | 2014-07-25 | Apparatus and method for modulating sleep |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016532485A JP2016532485A (ja) | 2016-10-20 |
JP2016532485A5 JP2016532485A5 (ja) | 2017-08-24 |
JP6641271B2 true JP6641271B2 (ja) | 2020-02-05 |
Family
ID=52393858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016530061A Active JP6641271B2 (ja) | 2013-07-26 | 2014-07-25 | 睡眠を調整する器械及び方法 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3024525B1 (ja) |
JP (1) | JP6641271B2 (ja) |
AU (1) | AU2014293008B2 (ja) |
CA (1) | CA2918317C (ja) |
WO (1) | WO2015013576A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2980452A1 (en) | 2015-04-01 | 2016-10-06 | Marcio Marc Abreu | Analysis of temperature signals from an abreu brain thermal tunnel |
CN108430568B (zh) * | 2015-12-22 | 2022-09-27 | 皇家飞利浦有限公司 | 基于睡眠深度在睡眠期间调节感觉刺激的强度的系统和方法 |
WO2018104309A1 (en) * | 2016-12-06 | 2018-06-14 | Koninklijke Philips N.V. | System and method for facilitating wakefulness |
FR3067241B1 (fr) | 2017-06-12 | 2021-05-28 | Rythm | Systeme habitronique pour l'assistance a l'endormissement |
JP2019208558A (ja) * | 2018-05-31 | 2019-12-12 | 株式会社デンソー | 体温調節器 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5871526A (en) * | 1993-10-13 | 1999-02-16 | Gibbs; Roselle | Portable temperature control system |
JP2005124609A (ja) * | 2003-10-21 | 2005-05-19 | Sumitomo Rubber Ind Ltd | 電子枕 |
JP2007175476A (ja) * | 2005-11-29 | 2007-07-12 | Seishi Takagi | 温度調整マット |
US8236038B2 (en) * | 2006-04-20 | 2012-08-07 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Method and apparatus of noninvasive, regional brain thermal stimuli for the treatment of neurological disorders |
US8425583B2 (en) * | 2006-04-20 | 2013-04-23 | University of Pittsburgh—of the Commonwealth System of Higher Education | Methods, devices and systems for treating insomnia by inducing frontal cerebral hypothermia |
WO2008129357A2 (en) * | 2006-12-26 | 2008-10-30 | Thermaquatic, Inc. | Heating and cooling pad, control unit therefor, system and method |
US8316649B2 (en) * | 2007-01-12 | 2012-11-27 | Superior Quilting Ltd. | Thermal controlled pillow |
US8628462B2 (en) * | 2008-10-07 | 2014-01-14 | Advanced Brain Monitoring, Inc. | Systems and methods for optimization of sleep and post-sleep performance |
US8355769B2 (en) * | 2009-03-17 | 2013-01-15 | Advanced Brain Monitoring, Inc. | System for the assessment of sleep quality in adults and children |
CA2787501A1 (en) * | 2010-01-27 | 2011-08-04 | Bruder Healthcare Company | Heating element with thermal fuse |
CA2890215A1 (en) * | 2012-11-15 | 2014-05-22 | Cereve, Inc. | Non-invasive brain temperature regulating devices for enhancing sleep |
CA2896950C (en) * | 2013-01-02 | 2021-10-19 | Cereve, Inc. | Systems for enhancing sleep |
-
2014
- 2014-07-25 WO PCT/US2014/048128 patent/WO2015013576A1/en active Application Filing
- 2014-07-25 JP JP2016530061A patent/JP6641271B2/ja active Active
- 2014-07-25 AU AU2014293008A patent/AU2014293008B2/en active Active
- 2014-07-25 CA CA2918317A patent/CA2918317C/en active Active
- 2014-07-25 EP EP14830124.5A patent/EP3024525B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2918317C (en) | 2023-02-28 |
EP3024525A1 (en) | 2016-06-01 |
CA2918317A1 (en) | 2015-01-29 |
AU2014293008A1 (en) | 2016-01-28 |
EP3024525A4 (en) | 2017-06-14 |
AU2014293008B2 (en) | 2019-01-17 |
EP3024525B1 (en) | 2021-11-17 |
JP2016532485A (ja) | 2016-10-20 |
WO2015013576A1 (en) | 2015-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10213334B2 (en) | Apparatus and method for modulating sleep | |
US10610661B2 (en) | Noninvasive, regional brain thermal stimuli for the treatment of migraine | |
US11744382B2 (en) | Article comprising a temperature-conditioned surface, thermoelectric control unit, and method for temperature-conditioning the surface of an article | |
JP5072955B2 (ja) | 非侵襲的、局所的な脳熱刺激により神経疾患を治療する方法及び装置 | |
US20170252534A1 (en) | Forehead cooling method and device to stimulate the parasympathetic nervous system for the treatment of insomnia | |
US9492313B2 (en) | Method and apparatus of noninvasive, regional brain thermal stimuli for the treatment of neurological disorders | |
JP2018102934A (ja) | 前庭刺激デバイス | |
JP6641271B2 (ja) | 睡眠を調整する器械及び方法 | |
US20200046936A1 (en) | Noninvasive, regional brain thermal stimulation for inducing relaxation | |
US20170319815A1 (en) | Method and apparatuses for modulating sleep by chemical activation of temperature receptors | |
US11896132B2 (en) | System for heat exchange with a circulating fluid | |
AU2017268269A1 (en) | Forehead cooling method and device to stimulate the parasympathetic nervous system for the treatment of insomnia | |
US20230046024A1 (en) | Noninvasive, Regional Brain Thermal Stimuli for the Treatment of Neurological Disorders | |
US20230050908A1 (en) | Noninvasive, Regional Brain Thermal Stimulation for Inducing Relaxation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20170420 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170713 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170713 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180516 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180604 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180903 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190124 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190424 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190723 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191128 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20191227 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6641271 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |